Works matching IS 10538569 AND DT 2004 AND VI 13 AND IP 4
Results: 11
Health outcomes among patients receiving oseltamivir.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. 227, doi. 10.1002/pds.845
- By:
- Publication type:
- Article
What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. 201, doi. 10.1002/pds.856
- By:
- Publication type:
- Article
Looking to the 21st century: have we learned from our mistakes, or are we doomed to compound them?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. 257, doi. 10.1002/pds.903
- By:
- Publication type:
- Article
Physician adherence to recommendations for duration of empiric antibiotic treatment for uncomplicated urinary tract infection in women: a national drug utilization analysis.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. 239, doi. 10.1002/pds.862
- By:
- Publication type:
- Article
Defining hormone replacement therapy in longitudinal studies: impact on measures of effect.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. 215, doi. 10.1002/pds.844
- By:
- Publication type:
- Article
Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. 207, doi. 10.1002/pds.872
- By:
- Publication type:
- Article
Current awareness: Pharmacoepidemiology and drug safety.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. i, doi. 10.1002/pds.917
- Publication type:
- Article
Risk factors ... but only after excluding high-risk subjects.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. 253, doi. 10.1002/pds.930
- By:
- Publication type:
- Article
A retrospective survey on the safety of Replenine®, a high-purity factor IX concentrate. E.W.Gascoigne, C.H. Dash, C.Harman and D.Wilmot. Pharmacoepidemiology and Drug Safety 13(3) 2004, 187-195.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. 267, doi. 10.1002/pds.970
- Publication type:
- Article
Solving Mr Peterson's doubts.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. 255, doi. 10.1002/pds.934
- By:
- Publication type:
- Article
A retrospective survey on the safety of Replenate®, a high-purity factor VIII concentrate.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2004, v. 13, n. 4, p. 243, doi. 10.1002/pds.956
- By:
- Publication type:
- Article